Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two-versus three-sample method for estimating gentamicin pharmacokinetic values

L A Lavezo1, R L Davis

  • 1Pharmacy Department, Veterans Affairs Medical Center, Albuquerque, NM 87108.

American Journal of Hospital Pharmacy
|April 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene.

Stem cell research·2023
Same author

A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin.

Clinical pharmacology and therapeutics·2016
Same author

Transcriptome sequencing implicates dorsal striatum-specific gene network, immune response and energy metabolism pathways in bipolar disorder.

Molecular psychiatry·2016
Same author

Novel, primate-specific PDE10A isoform highlights gene expression complexity in human striatum with implications on the molecular pathology of bipolar disorder.

Translational psychiatry·2016
Same author

Gravitational Waves and the Cosmic Microwave Background.

Annals of the New York Academy of Sciences·2015
Same author

A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.

Journal of neurology·2015
Same journal

National health care reform, Part 2: Response to pharmacists.

American journal of hospital pharmacy·1994
Same journal

Validity of originality assessment.

American journal of hospital pharmacy·1994
Same journal

Unit dose dispensing of chromic phosphate P 32 suspension.

American journal of hospital pharmacy·1994
Same journal

Hydralazine injection still available.

American journal of hospital pharmacy·1994
Same journal

Improved extemporaneous formulation of cyclosporine ophthalmic drops.

American journal of hospital pharmacy·1994
Same journal

Paclitaxel diluent and the case of the slippery spike.

American journal of hospital pharmacy·1994
See all related articles

Comparing two-sample and three-sample methods for estimating gentamicin pharmacokinetics, this study found both methods accurately predicted patient outcomes. The three-sample method showed less bias in predicting trough serum gentamicin concentrations.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Pharmacokinetics

Background:

  • Gentamicin is an antibiotic requiring careful dosage adjustments to ensure efficacy and minimize toxicity.
  • Accurate estimation of pharmacokinetic parameters is crucial for optimizing gentamicin therapy.
  • Existing methods for gentamicin pharmacokinetic estimation include two-sample and three-sample approaches.

Purpose of the Study:

  • To compare the performance of two-sample and three-sample methods for estimating gentamicin pharmacokinetic values.
  • To evaluate the accuracy and bias of each method in predicting gentamicin concentrations and optimizing dosage regimens.

Main Methods:

  • Retrospective review of medical records of 27 male patients receiving gentamicin dosage consultations.
  • Prospective use of three serum gentamicin concentrations (SGCs) in the three-sample method.

Related Experiment Videos

  • Retrospective use of initial peak and trough SGCs in the two-sample method.
  • Comparison of estimated pharmacokinetic values and predicted SGCs between the two methods and actual values.
  • Main Results:

    • Both two-sample and three-sample methods yielded estimates not significantly different from actual pharmacokinetic values.
    • Significant differences were observed in elimination rate constant and half-life estimates between the two methods.
    • No significant differences were found in clearance, volume of distribution, or required daily dose.
    • The three-sample method demonstrated less bias in predicting trough SGCs compared to the two-sample method.

    Conclusions:

    • Both two-sample and three-sample methods are reliable for estimating gentamicin pharmacokinetics in middle-aged and elderly men.
    • While statistically significant differences exist in some parameters, they are likely not clinically significant.
    • The three-sample method offers a slight advantage in predicting trough concentrations, potentially improving dosage regimen accuracy.